Why Should We Measure Serum Levels of Anticonvulsant Drugs in Epilepsy?

Abstract

Get full access to this article

View all access options for this article.

References

Rose

S. W.

Smith

L. D.

Penry

J. K.

(1971) Blood Level Determination of Antiepileptic Drugs: Clinical Value and Methods. Washington: U.S. Department of Health, Education & Welfare.

Garrettson

L. K.

(1972) ‘Pharmacology of anticonvulsants.‘ Pediatric Clinics of North America, 19, 179.

Baumel

I. P.

Gallagher

B. B.

Mattson

B. H.

(1972) ‘Phenylethylmalonamide (PEMA): an important metabolite of primidone.’ Archives of Neurology, 27, 34.

Kutt

Haynes

Mcdowell

(1966) ‘Some cases of ineffectiveness of diphenylhydantoin.’ Archives of Neurology, 14, 489.

Toseland

P. A.

(1972) Informal communication to the 8th International Study Group on Child Neurology and Cerebral Palsy, Oxford.

Lascelles

P. T.

Kocen

R. S.

Reynolds

E. H.

(1970) ‘The distribution of plasma phenytoin levels in epileptic patients.’ Journal of Neurology, Neurosurgery and Psychiatry, 33, 501.

Hutt

S. J.

Jackson

P. M.

Belsham

Higgins

(1968) ‘Perceptual-motor behaviour in relation to blood phenobarbitone level: a preliminary report.’ Developmental Medicine and Child Neurology, 19, 626.

Lennox-Buchthal

M. A.

(1972) ‘Febrile convulsions, aspects of prevention.’ Paper presented at the 8th International Study Group on Child Neurology and Cerebral Palsy, Oxford.